NMR spectroscopy of macrophages loaded with native, oxidized or enzymatically degraded lipoproteins

PLoS One. 2013;8(2):e56360. doi: 10.1371/journal.pone.0056360. Epub 2013 Feb 15.

Abstract

Oxidized and enzymatically modified low-density lipoproteins (oxLDL and eLDL) play a key role in early stages of atherogenesis. Their uptake by recruited macrophages leads to endolysosomal phospholipidosis or foam cell formation, respectively, each of which is preceded by highly differential lipid restructuring processes. We applied (1)H-NMR spectroscopy (NMRS) to elucidate these structural rearrangements both in consequence of lipoprotein modifications and following phagocytosis. Being specifically sensitive to the mobile lipid subset, NMRS of oxLDL and eLDL revealed a partial and total immobilization of lipids, respectively. NMRS of intact macrophages showed a sixfold increase in mobile lipids in case of loading with eLDL but no significant changes for oxLDL or native LDL. This finding reflected the disparate lipid storage in lipid droplets and in multilamellar endolysosomal clusters when loaded with either eLDL or oxLDL, respectively. Moreover, a significant shift of the degree of saturation towards mainly polyunsaturated fatty acid chains was found for the mobile lipid pool in eLDL-loaded macrophages. Additional analyses of lipid extracts by NMRS and mass spectrometry (MS) reflected these changes in lipid content and in fatty acid composition only partially. In summary, in-cell NMRS represents a unique lipidomics tool to investigate structural changes within the mobile lipid pool following atherogenic triggers that can be not detected by the analysis of lipid extracts by MS or NMRS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Lipoproteins, LDL / chemistry*
  • Lipoproteins, LDL / metabolism*
  • Macrophages / chemistry
  • Macrophages / metabolism*
  • Nuclear Magnetic Resonance, Biomolecular*
  • Oxidation-Reduction
  • Proteolysis*

Substances

  • Lipoproteins, LDL
  • oxidized low density lipoprotein

Grants and funding

This work was supported by the Fonds of the Chemical Industry (FCI) and by funding from the European Community’s Seventh Framework Programme (FP7/2007–2013) under grant agreement n° 202272, IP-Project LipidomicNet and the BMBF network project “Systems Biology Consortium on Metabotypes (SysMBo).” The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.